VIRX: Viracta Therapeutics, Inc. Stock

by  •  • Comments Off on VIRX: Viracta Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 33.26
Enterprise Value ($M) 51.67
Book Value ($M) 18.32
Book Value / Share 0.47
Price / Book 1.82
NCAV ($M) 16.59
NCAV / Share 0.42
Price / NCAV 2.00

Profitability (mra)
Return on Invested Capital (ROIC) -1.16
Return on Assets (ROA) -0.60
Return on Equity (ROE) -0.84

Liquidity (mrq)
Quick Ratio 1.43
Current Ratio 1.43

Balance Sheet (mrq) ($M)
Current Assets 54.96
Assets 56.69
Liabilities 38.37
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -50.69
Net Income -51.06
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -39.89
Cash from Investing 15.00
Cash from Financing 0.44

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G Forward Ventures V Lp 6.65 -3.65

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 14,476 36,384 39.79
2024-04-25 2,150 36,664 5.86
2024-04-24 6,995 50,415 13.87
2024-04-23 37,845 7,110 532.28
2024-04-22 3,328 2,170 153.36

(click for more detail)

Similar Companies
VERV – Verve Therapeutics, Inc. VIGL – Vigil Neuroscience, Inc.
VIR – Vir Biotechnology, Inc. VOR – Vor Biopharma Inc.
VRTX – Vertex Pharmaceuticals Incorporated


Financial data and stock pages provided by
Fintel.io